Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section

NACompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

January 22, 2022

Study Completion Date

January 22, 2022

Conditions
Postpartum Hemorrhage
Interventions
DRUG

I.V Oxytocin administration

Group I: Oxytocin( the oxytocin infusion consisting of 20 IU dissolved in 500 mL of normal 0.9 % sodium chloride solution and infused at a rate of 125 mL/h was administered immediately after clamping the umbilical cord). Group II:oxytocin plus intrauterine misoprostol (the oxytocin infusion was administered immediately after clamping the umbilical cord and misoprostol tablet (400 mg) was placed into uterine cavity at the fundus after delivery of the placenta and swabbing the cavity. Group III:100-mg carbetocin was intravenously administered immediately after birth of the baby.

Trial Locations (2)

Unknown

Bezmialem Vakif University, Istanbul

Bezmialem Vakif University, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER